Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
152M
-
Number of holders
-
174
-
Total 13F shares, excl. options
-
149M
-
Shares change
-
+6.31M
-
Total reported value, excl. options
-
$538M
-
Value change
-
+$26.5M
-
Put/Call ratio
-
6.67
-
Number of buys
-
89
-
Number of sells
-
-80
-
Price
-
$3.62
Significant Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) as of Q2 2024
215 filings reported holding ADPT - Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share as of Q2 2024.
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) has 174 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 149M shares
of 152M outstanding shares and own 97.89% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (30M shares), Rubric Capital Management LP (14M shares), BlackRock Inc. (11.7M shares), Matrix Capital Management Company, LP (11.6M shares), ARK Investment Management LLC (11.4M shares), VANGUARD GROUP INC (10.2M shares), MILLENNIUM MANAGEMENT LLC (9.26M shares), Nikko Asset Management Americas, Inc. (6.92M shares), Sumitomo Mitsui Trust Holdings, Inc. (6.9M shares), and MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (3.91M shares).
This table shows the top 174 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.